Literature DB >> 8551637

Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).

J K Wakefield1, S M Kang, C D Morrow.   

Abstract

The initiation of human immunodeficiency virus type 1 reverse transcription occurs by extension of a tRNA(Lys3) primer bound near the 5' end of the viral RNA genome which is designated the primer binding site (PBS). Sequences within the viral genome upstream of the PBS which are complementary to the anticodon loop (USUU) and the T psi C loop and arm (AGGGTm psi) of tRNA(Lys3) are postulated to play a role in maintaining the selective use of tRNA(Lys3) in reverse transcription. To investigate this possibility, proviral genomes which contain a PBS complementary to the 3'-terminal 18 nucleotides of tRNA(His) [pHXB2(His)] as well as sequences upstream of this PBS which are complementary to either the anticodon loop [CCACAA; pHXB2(His-AC)] or T psi C loop [GACCGAGG; pHXB2(His-T psi C)] of tRNA(His) were constructed. Infectious virus was recovered upon transfection into COS-1 cells of pHXB2(His), pHXB2(His-AC), or pHXB2(His-T psi C). The appearance of infectious virus after cocultivation with SupT1 cells was delayed for the proviruses containing a PBS complementary to tRNA(His) compared with that obtained by transfection of the wild-type provirus [pHXB2(WT)]. However, by several passages in SupT1 cells, the mutant viruses demonstrated replication kinetics similar to those of the wild-type virus. A DNA sequence analysis of the PBS region from integrated proviruses revealed that by day 15 of culture, the PBS of viruses derived from pHXB2(His) and pHXB2(His-T psi C) reverted back to the wild-type PBS complementary to tRNA(Lys3). In contrast, viruses derived from pHXB2(His-AC) maintained a PBS complementary to tRNA(His) for over 4 months in culture encompassing 12 serial passages. This study, then, is the first report of a stable human immunodeficiency virus type 1 which utilizes an alternative tRNA primer and suggests that interactions between the primer tRNA anticodon loop and viral sequences upstream of the PBS contribute to the specificity of the tRNA primer used in reverse transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551637      PMCID: PMC189901     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Variable tRNA content in HIV-1IIIB.

Authors:  M Jiang; J Mak; M A Wainberg; M A Parniak; E Cohen; L Kleiman
Journal:  Biochem Biophys Res Commun       Date:  1992-06-30       Impact factor: 3.575

2.  Analysis of the interactions of HIV1 replication primer tRNA(Lys,3) with nucleocapsid protein and reverse transcriptase.

Authors:  C Barat; O Schatz; S Le Grice; J L Darlix
Journal:  J Mol Biol       Date:  1993-05-20       Impact factor: 5.469

3.  Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription.

Authors:  C Isel; R Marquet; G Keith; C Ehresmann; B Ehresmann
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

4.  Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication.

Authors:  A H Lund; M Duch; J Lovmand; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

5.  Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer).

Authors:  C Isel; C Ehresmann; G Keith; B Ehresmann; R Marquet
Journal:  J Mol Biol       Date:  1995-03-24       Impact factor: 5.469

6.  Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.

Authors:  M Jiang; J Mak; A Ladha; E Cohen; M Klein; B Rovinski; L Kleiman
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.

Authors:  J K Wakefield; H Rhim; C D Morrow
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Reverse transcriptase of human immunodeficiency virus can use either human tRNA(3Lys) or Escherichia coli tRNA(2Gln) as a primer in an in vitro primer-utilization assay.

Authors:  L A Kohlstaedt; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

10.  Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.

Authors:  J Mak; M Jiang; M A Wainberg; M L Hammarskjöld; D Rekosh; L Kleiman
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  70 in total

1.  In vitro evidence for the interaction of tRNA(3)(Lys) with U3 during the first strand transfer of HIV-1 reverse transcription.

Authors:  F Brulé; G Bec; G Keith; S F Le Grice; B P Roques; B Ehresmann; C Ehresmann; R Marquet
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

2.  Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

3.  Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplex.

Authors:  F Freund; F Boulmé; S Litvak; L Tarrago-Litvak
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

4.  Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex.

Authors:  Fabienne Brulé; Roland Marquet; Liwei Rong; Mark A Wainberg; Bernard P Roques; Stuart F J Le Grice; Bernard Ehresmann; Chantal Ehresmann
Journal:  RNA       Date:  2002-01       Impact factor: 4.942

5.  The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity.

Authors:  C Liang; X Li; L Rong; P Inouye; Y Quan; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Authors:  X Li; C Liang; Y Quan; R Chandok; M Laughrea; M A Parniak; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

7.  Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers.

Authors:  X Wei; M Götte; M A Wainberg
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

8.  Essential regions of the tRNA primer required for HIV-1 infectivity.

Authors:  Q Yu; C D Morrow
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

9.  Does the HIV-1 primer activation signal interact with tRNA3(Lys) during the initiation of reverse transcription?

Authors:  Valérie Goldschmidt; Chantal Ehresmann; Bernard Ehresmann; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

10.  Structure-function relationships of the initiation complex of HIV-1 reverse transcription: the case of mutant viruses using tRNA(His) as primer.

Authors:  Mickaël Rigourd; Valérie Goldschmidt; Fabienne Brulé; Casey D Morrow; Bernard Ehresmann; Chantal Ehresmann; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.